Aurora Biosciences Gets $75 M Private Placement

Feb 10, 2000

Premium

S

AN DIEGO--Aurora Biosciences has agreed to sell 1.8 million shares of newly issued common stock to selected institutional and other accredited investors for $75 million. The purchase price is $42 per share. The company intends to use net proceeds from this private placement for development and acquisition of new technologies, particularly in genomics and drug discovery, as well as commercial development and for working capital and other general corporate purposes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Nov

05

Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Main menu